(Q54652433)

2 June 2018

title

Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status (English)

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

5 July 2024

author name string

Hee Jeong Kim

1

1 reference

2 June 2018

Mi-Jung Kim

2

1 reference

2 June 2018

Sei Hyun Ahn

3

1 reference

2 June 2018

Byung Ho Son

4

1 reference

2 June 2018

Sung Bae Kim

5

1 reference

2 June 2018

Jin Hee Ahn

6

1 reference

2 June 2018

Woo Chul Noh

7

1 reference

2 June 2018

Gyungyub Gong

8

1 reference

2 June 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20810282

5 July 2024

publication date

1 February 2011

1 reference

2 June 2018

full work available at URL

https://doi.org/10.1016/j.breast.2010.08.001

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20810282

https://api.elsevier.com/content/article/PII:S0960977610001797?httpAccept=text/xml

5 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

https://api.elsevier.com/content/article/PII:S0960977610001797?httpAccept=text/plain

5 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

5 July 2024

1 reference

2 June 2018

volume

20

1 reference

2 June 2018

issue

1

1 reference

2 June 2018

page(s)

78-85

1 reference

2 June 2018

Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy

cites work

4

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Prospective identification of tumorigenic breast cancer cells

5 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas

5 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Breast cancer, stem/progenitor cells and the estrogen receptor

5 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Recent translational research: stem cells as the roots of breast cancer

5 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Histological grading of breast carcinomas: a study of interobserver agreement.

5 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Breast tumor heterogeneity: cancer stem cells or clonal evolution?

5 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

5 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.

5 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

5 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

5 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 expression is a new prognostic marker in breast cancer

5 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 is a marker for human breast carcinoma

5 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.

5 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells

5 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients.

5 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Gene expression patterns associated with the metastatic phenotype in rodent and human tumors

5 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases

5 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers.

5 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study

5 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer

5 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.

5 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

CD44 isoforms in prognosis of breast cancer

5 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer

5 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment.

5 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

5 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

Molecular definition of breast tumor heterogeneity

5 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BREAST.2010.08.001

5 July 2024

Identifiers

1 reference

2 June 2018

1 reference

2 June 2018